Notes From BIO 2015 #1 Recap And Biotechnology Trends-M&A, Precision Medicine By: TalkMarkets June 25, 2015 at 04:58 AM EDT Many of the hottest stocks in 2015 are in “rare diseases” with multi-$B market caps with no approved products in the market. Read More >> Related Stocks: AbbVie Biomarin Pharmaceuticals Bluebird Bio Illumina Inc Sarepta Therapeutics Valeant Pharmaceuticals International, Inc.